Surrey Heartlands

Joint Formulary & PAD

Etoricoxib - Pain & inflammation - musculoskeletal

You are here : Home > Formulary Search > Etoricoxib - Pain & inflammation - musculoskeletal

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green (see narrative)
Formulations :
  • Tablets
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
BNF SPC
Restrictions / Comments :

Documentation

Safety Information
NSAIDs - Safer Prescribing Aide Memoir - Jul 2019
Evidence Review
COX-II colour change classification paper Jul-19.docx

PAD Profile

ChemicalSubstance :
Etoricoxib
Indication :
Pain & inflammation - musculoskeletal
Group Name :
Keywords :
COXIIs, Coxib, Cox-2, cyclo-oxygenase-2, osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, acute gouty arthritis, PNMP
Brand Names Include :
Arcoxia
Important Information :
2nd line COXX II except for gouty arthritis where etoricoxib is the preferred COX II
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
2

Other Indications

Below are listed other indications that Etoricoxib is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Pain & inflammation - musculoskeletal.

Committee Recommendations (1)

03 Jul 19 - Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)

The Surrey & North West Sussex Area Prescribing Committee recommends etoricoxib as a treatment option for the treatment of pain and inflammation in line with the product licence*.

Etoricoxib will be considered as GREEN on the traffic light system as a 2nd line COX-2 inhibitor (after celecoxib) for use where a COX-2 inhibitor is indicated.

If etoricoxib is indicated for the treatment of gouty arthritis then etoricoxib should be considered before celecoxib as it is licensed for this indication.

*Licenced for: Osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, acute gouty arthritis

The branded product, Arcoxia, is considered BLACK. Please prescribe generically for this indication.